IVERIC bio Inc.

NASDAQ: ISEE · Real-Time Price · USD
39.95
0.15 (0.38%)
At close: Jul 10, 2023, 10:00 PM

IVERIC bio Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
Net Income
-185.21M -114.52M
Depreciation & Amortization
138K 39K
Stock-Based Compensation
26.68M 11.24M
Other Working Capital
-14.67M 3.38M
Other Non-Cash Items
-688K 54K
Deferred Income Tax
n/a 1.18M
Change in Working Capital
-4.69M 3.44M
Operating Cash Flow
-163.77M -98.56M
Capital Expenditures
-736K -361K
Cash Acquisitions
n/a n/a
Purchase of Investments
-231.04M -142.82M
Sales Maturities Of Investments
181M 164.48M
Other Investing Acitivies
500K n/a
Investing Cash Flow
-50.28M 21.3M
Debt Repayment
n/a n/a
Common Stock Repurchased
n/a n/a
Dividend Paid
n/a n/a
Other Financial Acitivies
428.9M 272.33M
Financial Cash Flow
428.9M 272.33M
Net Cash Flow
214.86M 195.07M
Free Cash Flow
-164.51M -98.92M